Dr Roland Ruscher, an immunologist JCU’s Australian Institute of Tropical Health and Medicine, said IBD affects more than six million people worldwide. The disease incurs costs of more than $3 billion a year in Australia, while colorectal cancer claims around 900,000 lives globally every year.
“The peak onset age of IBD is in early adulthood, while colorectal cancer predominantly affects people over 50 years of age. Both conditions are associated with the malfunction of immune cells in the gut named intraepithelial lymphocytes (IEL) that help protect the body from infection.”
Gut microbiome – artistic visualization. Image credit: IBM Research via Flickr, CC BY-ND 2.0
Dr Ruscher said how gut immunity fails in the context of age is poorly understood.
“My working theory is that IEL in younger people are prone to overactivation, tipping them from a regulatory towards a tissue-destructive state that helps cause IBD, while during old age their functionality decreases, rendering IEL less effective at eliminating cancerous gut cells,” said Dr Ruscher.
The Australian Government’s National Health and Medical Research Council has just granted Dr Ruscher more than $600,000 to test the theory over the next five years.
Dr Ruscher said the research will establish parameters of the intestinal immune system over different stages in life.
“By the end of the five years, I will have answers to longstanding questions about IEL and their roles in age-associated diseases. My vision is to advance the understanding of IEL at different life stages, with the overarching aim of significantly improving treatment for IBD and colorectal cancer.”
Source: James Cook University